SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 150.55.
Share Price | ₹164.5 | Feb 05,2025 |
Market Cap | ₹4,117.4 Cr | |
Earnings-TTM | ₹27.4 Cr | TTM-Consolidated Results |
Price/Earnings | 150.55x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹4,117.4 Cr] as on Feb 05,2025
(/) Earnings [ ₹27.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 150.55x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 150.55 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 34.29x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 27.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2022 at 81.14x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SEQUENT SCIENTIFIC | 27.35 | 150.55 | 4,117.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.63 | 420,699.0 |
CIPLA LTD | 5,000.43 | 23.20 | 116,022.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.87 | 102,463.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 21.44 | 98,434.8 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.66 | 162,584.0 |
MANKIND PHARMA LTD | 2,050.73 | 49.96 | 102,447.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 56.63 | 105,449.0 |
LUPIN LTD | 2,651.94 | 37.64 | 99,816.4 |
AUROBINDO PHARMA LTD | 3,598.83 | 19.23 | 69,222.8 |
ABBOTT INDIA LTD | 1,334.46 | 44.24 | 59,040.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.87x |
Max industry PE | 150.55x |
Median industry PE | 37.64x |
Average industry PE | 48.82x |
You may also like the below Video Courses